Abstract:Abstract Background Vasculogenic mimicry (VM) is a recently discovered angiogenetic process found in many malignant tumors, and is different from the traditional angiogenetic process involving vascular endothelium. It involves the formation of microvascular channels composed of tumor cells; therefore, VM is considered a new model for the formation of new blood vessels in aggressive tumors, and can provide blood supply for tumor growth. Many studies have pointed out that in recent years, some clinical treatments against angiogenesis have not been satisfactory possibly due to the activation of VM. Although the mechanisms underlying VM have not been fully elucidated, increasing research on the soil “microenvironment” for tumor growth suggests that the initial hypoxic environment in solid tumors is inseparable from VM. Main body In this review, we describe that the stemness and differentiation potential of cancer stem cells are enhanced under hypoxic microenvironments, through hypoxia-induced epithelial-endothelial transition (EET) and extracellular matrix (ECM) remodeling to form the specific mechanism of vasculogenic mimicry; we also summarized some of the current drugs targeting VM through these processes, suggesting a new reference for the clinical treatment of tumor angiogenesis. Conclusion Overall, the use of VM inhibitors in combination with conventional anti-angiogenesis treatments is a promising strategy for improving the effectiveness of targeted angiogenesis treatments; further, considering the importance of hypoxia in tumor invasion and metastasis, drugs targeting the hypoxia signaling pathway seem to achieve good results.

Progress in Research on the Relationships among Tumor Blood Supply Patterns

Status and prospect of vascular mimicry in cancer research

Vasculogenic mimicry in carcinogenesis and clinical applications

The Hypoxia-Related Signaling Pathways of Vasculogenic Mimicry in Tumor Treatment.

Vasculogenic mimicry and microcirculation in tumors

Anti-angiogenic Therapy for Tumor: Tumor Angiogenesis, Vasculogenic Mimicry and Vascular Normalization

Vasculogenic Mimicry and Tumor Metastasis.

Overview of Advances in Vasculogenic Mimicry - a Potential Target for Tumor Therapy

Advances on Study of the Origin and Molecular Mechanism of Vasculogenic Mimicry

Molecular Regulation of Vasculogenic Mimicry in Tumors and Potential Tumor-Target Therapy

[Mechanism Exploration and Future Prospects of Antiangiogenic Agents Improving Tumor Blood Supply and Oxygenation].

The Origins Of Vacularization In Tumors

Tumor vascular biomarkers: new opportunities for cancer diagnostics.

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry

Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

Study of Tumor Blood Perfusion and Its Variation Due to Vascular Normalization by Anti-Angiogenic Therapy Based on 3D Angiogenic Microvasculature

The driving mechanism and targeting value of mimicry between vascular endothelial cells and tumor cells in tumor progression

Advances in tumor vascular growth inhibition

Tumor Vasculogenic Mimicry Formation As an Unfavorable Prognostic Indicator in Patients with Breast Cancer

The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions